Literature DB >> 30178024

Financial Conflicts of Interest Among Oncologist Authors of Reports of Clinical Drug Trials.

Cole Wayant1, Erick Turner2, Chase Meyer1, Philip Sinnett3, Matt Vassar1.   

Abstract

Mesh：

Year:  2018        PMID： 30178024      PMCID： PMC6233769          DOI： 10.1001/jamaoncol.2018.3738

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

1.  Unintended consequences of expensive cancer therapeutics—the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the John Conley Lecture.

Authors:  Tito Fojo; Sham Mailankody; Andrew Lo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-12       Impact factor: 6.223

2.  Beyond moral outrage--weighing the trade-offs of COI regulation.

Authors:  Lisa Rosenbaum
Journal:  N Engl J Med       Date:  2015-05-21       Impact factor: 91.245

3.  Five Years of Cancer Drug Approvals: Innovation, Efficacy, and Costs.

Authors:  Sham Mailankody; Vinay Prasad
Journal:  JAMA Oncol       Date:  2015-07       Impact factor: 31.777

4.  Closed Financial Loops: When They Happen in Government, They're Called Corruption; in Medicine, They're Just a Footnote.

Authors:  Kevin De Jesus-Morales; Vinay Prasad
Journal:  Hastings Cent Rep       Date:  2017-05       Impact factor: 2.683
  4 in total
  12 in total

1.  Preserving Independent Urology: LUGPA's First Decade.

Authors:  Neal D Shore; Deepak A Kapoor; Evan R Goldfischer; David C Chaikin; Earl L Walz; R Jonathan Henderson; Richard G Harris; Robert D Asinof; Gary M Kirsh
Journal:  Rev Urol       Date:  2019

2.  Financial Conflicts of Interest Change After a High-Impact Clinical Trial Publication in Oncology.

Authors:  Craig L Cambridge; Emily Stern Gatof; Glen J Weiss; Roger B Davis
Journal:  J Patient Cent Res Rev       Date:  2020-07-27

3.  Interactions with the pharmaceutical industry and the practice, knowledge and beliefs of medical oncologists and clinical haematologists: a systematic review.

Authors:  Adrian M J Pokorny; Alice Fabbri; Lisa A Bero; Ray Moynihan; Barbara J Mintzes
Journal:  Br J Cancer       Date:  2021-10-01       Impact factor: 9.075

Review 4.  An urgent call to raise the bar in oncology.

Authors:  John-John B Schnog; Michael J Samson; Rijk O B Gans; Ashley J Duits
Journal:  Br J Cancer       Date:  2021-08-16       Impact factor: 7.640

5.  Financial Conflicts of Interest of United States-Based Authors in Neurology Journals: Cross-Sectional Study Using the Open Payments Database.

Authors:  Jade E Smith; Charlotte Wahle; James L Bernat; Nathaniel M Robbins
Journal:  Neurology       Date:  2021-02-25       Impact factor: 9.910

6.  A cross-sectional examination of conflict-of-interest disclosures of physician-authors publishing in high-impact US medical journals.

Authors:  James H Baraldi; Steven A Picozzo; Jacob C Arnold; Kathryn Volarich; Michael R Gionfriddo; Brian J Piper
Journal:  BMJ Open       Date:  2022-04-11       Impact factor: 3.006

7.  Discordant financial conflicts of interest disclosures between clinical trial conference abstract and subsequent publication.

Authors:  Glen J Weiss; Roger B Davis
Journal:  PeerJ       Date:  2019-02-11       Impact factor: 2.984

8.  Editors' and authors' individual conflicts of interest disclosure and journal transparency. A cross-sectional study of high-impact medical specialty journals.

Authors:  Rafael Dal-Ré; Arthur L Caplan; Ana Marusic
Journal:  BMJ Open       Date:  2019-07-23       Impact factor: 2.692

9.  Reducing bias and improving transparency in medical research: a critical overview of the problems, progress and suggested next steps.

Authors:  Stephen H Bradley; Nicholas J DeVito; Kelly E Lloyd; Georgia C Richards; Tanja Rombey; Cole Wayant; Peter J Gill
Journal:  J R Soc Med       Date:  2020-11       Impact factor: 5.344

10.  Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012-2016).

Authors:  Piotr Ozieranski; Marcell Csanádi; Emily Rickard; Shai Mulinari
Journal:  BMJ Open       Date:  2020-09-19       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.